Related Experiment Video
Updated: Feb 17, 2026
07:01
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
9.5K
Epilepsy Treatment: A Futurist View
1Professor, Department of Neurology, Director, Epilepsy Center, University of Cincinnati Gardner Neuroscience Institute, 260 Stetson St; Suite 2300, Cincinnati, OH 45267-0525, Michael.privitera@uc.edu, 513-558-5440.
Epilepsy Currents
|December 12, 2017
Summary
Experts explored future epilepsy treatments, envisioning advancements beyond current research. This look into the future of epilepsy care aims to inspire innovation for the next generation of specialists and patients.
Area of Science:
- Neurology
- Epileptology
- Medical Futures
Background:
- Epilepsy treatment is advancing rapidly, making it difficult to stay current.
- The rapid pace of discovery challenges clinicians and researchers to envision future epilepsy care.
- The Presidential Symposium at the 2016 American Epilepsy Society Annual Meeting focused on future epilepsy treatment.
Purpose of the Study:
- To challenge experts to predict the future of epilepsy treatment for the next generation.
- To explore cutting-edge ideas and surprising predictions for epilepsy care.
- To stimulate imagination and drive future advancements in patient treatment.
Main Methods:
- Invited experts to present their visions for future epilepsy treatment.
- Summarized lectures covering current states, innovative ideas, and future predictions.
- Focused on forward-looking perspectives beyond immediate clinical and research work.
Main Results:
- Experts provided insights into the future landscape of epilepsy treatment.
- Discussions included current breakthroughs and speculative advancements.
- The symposium generated imaginative predictions for the coming decades.
Conclusions:
- The future of epilepsy treatment holds significant potential for innovation.
- Encouraging visionary thinking is crucial for advancing patient care.
- These predictions aim to inspire current practitioners to shape future epilepsy therapies.
More Related Videos
Related Concept Videos
01:24Epilepsy and Seizures: Overview
1.4K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.4K
01:14Antiepileptic Drugs: Glutamate Antagonists
1.0K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.0K
01:13Seizures: Classification
1.7K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.7K
01:30Electroconvulsive Therapy
1.3K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.3K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
944
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
944
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.4K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.4K